Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant - PubMed (original) (raw)
Review
Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant
Georgia B Vogelsang et al. Annu Rev Med. 2003.
Abstract
Stem cell transplantation is being used to treat a number of hematologic malignancies as well as hematologic and immune deficiency states. The ages of patients being offered this therapy and the donor marrow sources have been expanded. One persistent problem has been graft-versus-host disease (GVHD). This article reviews the basic biology of GVHD, clinical manifestations of acute and chronic GVHD, prophylaxis and treatment of acute GVHD, and treatment of chronic GVHD.
Similar articles
- Chronic graft-versus-host disease: clinical manifestation and therapy.
Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Ratanatharathorn V, et al. Bone Marrow Transplant. 2001 Jul;28(2):121-9. doi: 10.1038/sj.bmt.1703111. Bone Marrow Transplant. 2001. PMID: 11509929 Review. - Cutaneous graft-versus-host disease: a guide for the dermatologist.
Häusermann P, Walter RB, Halter J, Biedermann BC, Tichelli A, Itin P, Gratwohl A. Häusermann P, et al. Dermatology. 2008;216(4):287-304. doi: 10.1159/000113941. Epub 2008 Jan 29. Dermatology. 2008. PMID: 18230976 Review. - Ocular graft-versus-host disease: a review.
Shikari H, Antin JH, Dana R. Shikari H, et al. Surv Ophthalmol. 2013 May-Jun;58(3):233-51. doi: 10.1016/j.survophthal.2012.08.004. Epub 2013 Mar 27. Surv Ophthalmol. 2013. PMID: 23541042 Review. - Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL, Bloom EJ. Schwinghammer TL, et al. Clin Pharm. 1993 Oct;12(10):736-61. Clin Pharm. 1993. PMID: 8258255 Review.
Cited by
- Graph-Based Imputation Methods and Their Applications to Single Donors and Families.
Israeli S, Maiers M, Louzoun Y. Israeli S, et al. Methods Mol Biol. 2024;2809:193-214. doi: 10.1007/978-1-0716-3874-3_13. Methods Mol Biol. 2024. PMID: 38907899 - Advances in the ocular complications after hematopoietic stem cell transplantation.
Lv X, Li H, Su S, Fan S. Lv X, et al. Ann Hematol. 2024 Oct;103(10):3867-3880. doi: 10.1007/s00277-024-05678-z. Epub 2024 Feb 26. Ann Hematol. 2024. PMID: 38403713 Review. - Multi-parametric MRI in the diagnosis and scoring of gastrointestinal acute graft-versus-host disease.
Maccioni F, La Rocca U, Milanese A, Busato L, Cleri A, Lopez M, Manganaro L, De Felice C, Di Gioia C, Vestri AR, Catalano C, Iori AP. Maccioni F, et al. Eur Radiol. 2023 Sep;33(9):5911-5923. doi: 10.1007/s00330-023-09563-7. Epub 2023 Apr 18. Eur Radiol. 2023. PMID: 37071163 Free PMC article. - Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Keklik M, Deveci B, Celik S, Deniz K, Gonen ZB, Zararsiz G, Saba R, Akyol G, Ozkul Y, Kaynar L, Keklik E, Unal A, Cetin M, Jones OY. Keklik M, et al. Ann Hematol. 2023 Jun;102(6):1537-1547. doi: 10.1007/s00277-023-05216-3. Epub 2023 Apr 17. Ann Hematol. 2023. PMID: 37067556 - Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response.
Martinez-Sanchez J, Palomo M, Pedraza A, Moreno-Castaño AB, Torramade-Moix S, Rovira M, Salas MQ, Cid J, Escolar G, Penack O, Carreras E, Diaz-Ricart M. Martinez-Sanchez J, et al. J Cell Mol Med. 2023 May;27(9):1227-1238. doi: 10.1111/jcmm.17712. Epub 2023 Apr 4. J Cell Mol Med. 2023. PMID: 37016544 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical